Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the clinical performance and safety of a single knee injection combining hyaluronic acid HA and autologous platelet-rich plasma PRP compared with HA alone in adults with symptomatic knee osteoarthritis of moderate severity Kellgren-Lawrence grade II or III. Knee osteoarthritis causes pain and limits function, affecting quality of life. The study is a prospective, randomized, open-label follow-up to assess whether adding PRP to HA offers additional benefits. Participants will be randomly assigned to receive either one injection of 3.8 mL HA combined with 1 mL of PRP prepared from their own blood or one injection of 4.8 mL HA alone. Both treatments are administered as a single intra-articular injection into the knee. The study follows participants for 18 months to monitor outcomes and safety. During the study, participants will be assessed at multiple time points including baseline, 1, 3, 6, 12, and 18 months. Researchers will measure changes in knee pain using the Numeric Rating Scale NRS, as well as scores on the Western Ontario and McMaster Universities Osteoarthritis Index WOMAC and the Knee Injury and Osteoarthritis Outcome Score KOOS. Safety assessments and adverse events will be recorded throughout the follow-up period. The study aims to understand the effects and safety of these injection therapies over time.